Newsroom
November 14, 2006
The New Jersey Commission on Science and Technology awarded nearly $2.5 million to New Jersey companies at its November 14, 2006 Quarterly Commission Meeting.
Urovalve, Inc. of Newark, NJ was awarded an Entrepreneurial Fund Partnering Grant in the amount of $264,155.
The Commission provides funding of $100,000-$500,000 to New Jersey technology companies, in partnership with a New Jersey research university, for proof-of-concept research and development activities necessary for commercialization of an identified technology. The Entrepreneurial Partnering Fund promotes collaboration between universities and companies, increases the amount and value of intellectual property, provides early-stage financing and commercialization support and grows technology businesses in New Jersey.
The mission of Urovalve, Inc. is to design, develop, and commercialize superior medical devices that address problems with urinary flow and control. Three specific areas of interest are urinary retention; leakage (incontinence), and diagnostics (urodynamics). The current focus of the Company is on completing development, regulatory approval and commercialization of our initial device; a disposable, patient-controlled intraurethral valved-catheter that is intended to treat chronic male urinary retention (such as that caused by spinal cord injury and neurological diseases) and acute male urinary retention (such as that caused by prostate hypertrophy). Urovalve has developed technology to control fluid flow through small diameter flexible tubing.